Shteinberg M, Obradovic M, van der Laan R, Hoenig C, Legtenberg R, Reimann A
BMC Pulm Med. 2025; 25(1):85.
PMID: 39984983
PMC: 11846451.
DOI: 10.1186/s12890-025-03553-9.
Lee H, Jang J, Kim Y, Min K, Ahn J, Yoo K
J Pers Med. 2024; 14(11).
PMID: 39590581
PMC: 11595912.
DOI: 10.3390/jpm14111089.
Abate G, Meza K, Colbert C, Eickhoff C
Pathogens. 2024; 13(10).
PMID: 39452774
PMC: 11510112.
DOI: 10.3390/pathogens13100903.
Lee S, Chang S, Chung E, Park Y, Kang Y
Sci Rep. 2024; 14(1):22815.
PMID: 39354035
PMC: 11445539.
DOI: 10.1038/s41598-024-73768-z.
Yoon S, Kim H, Kim J, Kim J, Lee J
BMC Pulm Med. 2024; 24(1):432.
PMID: 39223547
PMC: 11367750.
DOI: 10.1186/s12890-024-03223-2.
Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China.
Lin W, Yao C, Mei L, Wang D, Bao X, Liu S
Am J Transl Res. 2024; 16(7):3298-3305.
PMID: 39114690
PMC: 11301460.
DOI: 10.62347/MAJY5046.
Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan.
Wang P, Morimoto K, Hasegawa N, Hassan M, Chatterjee A
ERJ Open Res. 2024; 10(4).
PMID: 38978557
PMC: 11228608.
DOI: 10.1183/23120541.00911-2023.
Nontuberculous mycobacterial infection in Wisconsin children and adolescents.
Vonasek B, Gusland D, Tans-Kersten J, Misch E, Gibbons-Burgener S
J Clin Tuberc Other Mycobact Dis. 2024; 36:100456.
PMID: 38974997
PMC: 11227012.
DOI: 10.1016/j.jctube.2024.100456.
CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis.
Yan Q, Zhao W, Kong H, Chi J, Dai Z, Yu D
Exp Ther Med. 2024; 27(3):112.
PMID: 38361522
PMC: 10867735.
DOI: 10.3892/etm.2024.12400.
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine.
Calcagno A, Coppola N, Sarmati L, Tadolini M, Parrella R, Matteelli A
Infection. 2024; 52(3):737-765.
PMID: 38329686
PMC: 11142973.
DOI: 10.1007/s15010-024-02183-3.
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.
Gramegna A, Misuraca S, Lombardi A, Premuda C, Barone I, Ori M
Respir Res. 2023; 24(1):316.
PMID: 38104098
PMC: 10725605.
DOI: 10.1186/s12931-023-02612-1.
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.
Prevots D, Marshall J, Wagner D, Morimoto K
Clin Chest Med. 2023; 44(4):675-721.
PMID: 37890910
PMC: 10625169.
DOI: 10.1016/j.ccm.2023.08.012.
Development of prevalence and incidence of non-tuberculous mycobacteria in German laboratories from 2016 to 2020.
Corbett C, Finger P, Heiss-Neumann M, Bohnert J, Eder I, Eisele M
Emerg Microbes Infect. 2023; 12(2):2276342.
PMID: 37883336
PMC: 10769520.
DOI: 10.1080/22221751.2023.2276342.
Best Practices for the Management of Patients with Non-Tuberculous Mycobacterial Pulmonary Disease According to a German Nationwide Analysis of Expert Centers.
Rohde G, Eichinger M, Glaser S, Heiss-Neumann M, Kehrmann J, Neurohr C
Healthcare (Basel). 2023; 11(19).
PMID: 37830647
PMC: 10572995.
DOI: 10.3390/healthcare11192610.
Correlation of drug exposure and bacterial susceptibility with treatment response for lung disease: protocol for a prospective observational cohort study.
Zheng X, Wang L, Forsman L, Zhang Y, Chen Y, Luo X
BMJ Open. 2023; 13(10):e075383.
PMID: 37788924
PMC: 10551947.
DOI: 10.1136/bmjopen-2023-075383.
Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians' Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland.
Przybylski G, Bukowski J, Kowalska W, Pilaczynska-Cemel M, Krawiecka D
Pathogens. 2023; 12(8).
PMID: 37623948
PMC: 10459785.
DOI: 10.3390/pathogens12080988.
Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.
Liu Q, Du J, An H, Li X, Guo D, Li J
Front Cell Infect Microbiol. 2023; 13:1205225.
PMID: 37424783
PMC: 10325861.
DOI: 10.3389/fcimb.2023.1205225.
Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews.
Hoenig C, van der Laan R, Reimann A, Hoffmann M, Tyler S, Wiesmann C
Adv Ther. 2023; 40(6):2915-2926.
PMID: 37150804
DOI: 10.1007/s12325-023-02519-9.
Nontuberculous Mycobacterial Infection in Wisconsin Adults and Its Relationship to Race and Social Disadvantage.
Vonasek B, Gusland D, Hash K, Wiese A, Tans-Kersten J, Astor B
Ann Am Thorac Soc. 2023; 20(8):1107-1115.
PMID: 36812384
PMC: 10405610.
DOI: 10.1513/AnnalsATS.202205-425OC.
Diagnosis and Management of Pulmonary NTM with a Focus on Complex and : Challenges and Prospects.
Hendrix C, McCrary M, Hou R, Abate G
Microorganisms. 2023; 11(1).
PMID: 36677340
PMC: 9861392.
DOI: 10.3390/microorganisms11010047.
